FindTrial
Sign In

Is procalcitonin useful in an newborn

A retrospective observational study of cord blood procalcitonin as a routine screening tool for the diagnosis of early onset neonatal sepsis in neonates born to mothers after assisted fertility

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/01/030457
Enrollment
90
Registered
2021-01-14
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O099- Supervision of high risk pregnancy, unspecified

Interventions

None listed

Sponsors

Gunasheela Surgical and Maternity Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All babies born to mothers who had assisted reproduction in Gunasheela surgical and maternity hospital, and all babies born to mothers who conceived spontaneously and delivered in Gunasheela surgical and maternity hospital.

Exclusion criteria

Exclusion criteria: Major congenital anomalies, Patient transfer to another hospital

Design outcomes

Primary

MeasureTime frame
Usefulness of procalcitonin in Assisted Reproductive Treatment in babiesTimepoint: December 2019 to April 2020—

Secondary

MeasureTime frame
Usefulness of procalcitonin in spontaneous pregnanciesTimepoint: December 2019 to April 2020—

Countries

India

Contacts

Public ContactDr Manjunath V

Gunasheela Surgical and Maternity Hospital

drmanjusharma@gmail.com080-46462600

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026